bioRxiv preprint doi: https://doi.org/10.1101/225524; this version posted November 27, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. GABAergic deficits and schizophrenia-like behaviors in a mouse model carrying patient-derived neuroligin-2 R215H mutation Dong-Yun Jiang1, Zheng Wu1, Yi Hu1, Siu-Pok Yee2, Gong Chen1, * 1. Department of Biology, Huck Institutes of Life Sciences, Pennsylvania State University, University Park, PA 16802 2. Department of Cell Biology, University of Connecticut Health center, Farmington, CT, 06030 Keywords: Schizophrenia, GABA, neuroligin-2, mouse model, mutation * Correspondence: Dr. Gong Chen Professor and Verne M. Willaman Chair in Life Sciences Department of Biology Pennsylvania State University University Park, PA 16802, USA Email:
[email protected] 1 bioRxiv preprint doi: https://doi.org/10.1101/225524; this version posted November 27, 2017. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under aCC-BY 4.0 International license. Abstract Schizophrenia (SCZ) is a severe mental disorder characterized by delusion, hallucination, and cognitive deficits. We have previously identified from schizophrenia patients a loss-of-function mutation Arg215àHis215 (R215H) of neuroligin 2 (NLGN2) gene, which encodes a cell adhesion molecule critical for GABAergic synapse formation and function. Here, we generated a novel transgenic mouse line with neuroligin-2 (NL2) R215H mutation, which showed a significant loss of NL2 protein, reduced GABAergic transmission, and impaired hippocampal activation.